Cargando…

Identification of pre-leukemic hematopoietic stem cells in acute leukemia

In acute myeloid leukemia (AML), the cell of origin, nature and biological consequences of initiating lesions and order of subsequent mutations remain poorly understood, as AML is typically diagnosed without observation of a pre-leukemic phase. Here, highly purified hematopoietic stem cells (HSC), p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shlush, Liran I., Zandi, Sasan, Mitchell, Amanda, Chen, Weihsu Claire, Brandwein, Joseph M., Gupta, Vikas, Kennedy, James A., Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., McLeod, Jessica L., Doedens, Monica, Medeiros, Jessie J.F., Marke, Rene, Kim, Hyeoung Joon, Lee, Kwon, McPherson, John D., Hudson, Thomas J., Brown, Andrew M.K., Trinh, Quang M., Stein, Lincoln D., Minden, Mark D., Wang, Jean C.Y., Dick, John E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991939/ https://www.ncbi.nlm.nih.gov/pubmed/24522528 http://dx.doi.org/10.1038/nature13038

Ejemplares similares

Evolutionary trajectory of leukemic clones and its clinical implications
por: Tuval, Amos, et al.
Publicado: (2019)

The role of mitochondrial proteases in leukemic cells and leukemic stem cells
por: Mirali, Sara, et al.
Publicado: (2020)

SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data
por: Medeiros, Jessie J F, et al.
Publicado: (2022)

The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
por: How, J, et al.
Publicado: (2013)

P421: TARGETED DISRUPTION OF HUMAN FLT3 ERADICATES LEUKEMIC STEM CELLS WITHOUT HARMING HEALTHY HEMATOPOIETIC STEM CELLS
por: Araújo, Joana, et al.
Publicado: (2023)

Clonal evolution of leukemia from G6PD studies
por: Bacharach, Tal, et al.
Publicado: (2023)

Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations
por: Calvillo-Argüelles, Oscar, et al.
Publicado: (2022)

In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
por: Vujovic, Ana, et al.
Publicado: (2023)

The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors
por: Liu, Lina, et al.
Publicado: (2022)

Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
por: Feldman, Tzah, et al.
Publicado: (2021)

Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells
por: Pando, Alejandro, et al.
Publicado: (2018)

Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemia
por: Tuval, Amos, et al.
Publicado: (2022)

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
por: Reed, Gregory A., et al.
Publicado: (2016)

Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis
por: Zioni, N., et al.
Publicado: (2023)

Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
por: Mer, Arvind Singh, et al.
Publicado: (2021)

S103: NATURAL AND AGE-RELATED VARIATION IN CIRCULATING HUMAN HEMATOPOIETIC STEM CELLS
por: Furer, Nili, et al.
Publicado: (2023)

Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature
por: Tavor, Sigal, et al.
Publicado: (2020)

Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness
por: Boileau, Meaghan, et al.
Publicado: (2019)

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
por: Laverdière, Isabelle, et al.
Publicado: (2018)

Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing
por: Abelson, Sagi, et al.
Publicado: (2020)

Low-dose salinomycin induces anti-leukemic responses in AML and MLL
por: Roulston, Gary D.R., et al.
Publicado: (2016)

IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells
por: Nachmias, Boaz, et al.
Publicado: (2022)

Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies
por: Chen, Weihsu C., et al.
Publicado: (2018)

SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress
por: Zipin-Roitman, Adi, et al.
Publicado: (2017)

FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome
por: Schieber, Michael, et al.
Publicado: (2020)

Targeting the leukemic bone marrow microenvironment
por: von der Heide, Eva Kristin, et al.
Publicado: (2017)

Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death
por: Longo, Joseph, et al.
Publicado: (2020)

ISOWN: accurate somatic mutation identification in the absence of normal tissue controls
por: Kalatskaya, Irina, et al.
Publicado: (2017)

SIRPαFc treatment targets human acute myeloid leukemia stem cells
por: Galkin, Oleksandr, et al.
Publicado: (2020)

An improved molecular inversion probe based targeted sequencing approach for low variant allele frequency
por: Biezuner, Tamir, et al.
Publicado: (2022)

Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells
por: Xu, G. Wei, et al.
Publicado: (2014)

Deciphering Metabolic Adaptability of Leukemic Stem Cells
por: Patel, Sweta B., et al.
Publicado: (2022)

Brightness perception under photopic conditions: experiments and modeling with contributions of S-cone and ipRGC
por: Khanh, Tran Quoc, et al.
Publicado: (2023)

Transmissible ER stress shapes the leukemic microenvironment
por: Butler, John T., et al.
Publicado: (2019)

Effects of plant-derived anti-leukemic drugs on individualized leukemic cell population profiles in Egyptian patients
por: ABOUL-SOUD, MOURAD A. M., et al.
Publicado: (2016)

Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities
por: Marchand, Tony, et al.
Publicado: (2021)

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen
por: Chen, Ruiqi, et al.
Publicado: (2020)

Rosacea Granulomatosis in a Neutropenic Leukemic Patient
por: Lee, Woo Joo, et al.
Publicado: (2022)

Necrotizing Cellulitis and Myositis in a Neutropenic Leukemic Patient
por: Alok, Akankcha, et al.
Publicado: (2021)

Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J
por: Shlush, Liran I., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_33s5tuu633tu03iiskf79rir3m